投融资数据库
免费查数据
注册送3天会员
首页>投融资
Inflammatix
E~PreIPO
Inflammatix is a molecular diagnostics company developing rapid tests that read the immune system using algorithms to generate clinically actionable results.In October 2020, Inflammatix announced a contract extension of $7.4 million from the Biomedical Advanced Research and Development Authority.In October 2020, Inflammatix announced a contract extension of $7.4 million from the Biomedical Advanced Research and Development Authority
基本信息
-
公司全称Inflammatix Inc
-
类型分子诊断技术及产品研发商
-
产业领域医疗器械、医疗信息化、AI+辅助诊断
-
公司人数15~50人
-
地址863 Mitten Road,Suite 104,Burlingame; US;
-
联系电话
-
邮箱info@inflammatix.com
-
成立时间2016-01-01
投融资
-
2024-09-12
-
2021-03-16
-
2020-09-29
-
2020-01-10
- 加载更多
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息